Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.8K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.7K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.7K
Production of Formed Elements01:34

Production of Formed Elements

3.5K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
3.5K
Lineage Commitment01:21

Lineage Commitment

4.0K
Commitment is the  process whereby stem cells:
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human leukocyte antigen-G in solid tumors: from immunotolerance to immunotherapy.

Frontiers in immunology·2026
Same author

Human leukocyte antigen-G isoform HLA-G2/6, but not HLA-G1/4/5, is an independent indicator of poor survival in patients with colorectal cancer.

Frontiers in immunology·2025
Same author

HLA-G expression in peritumoral fundic gland mucous neck cells, but not in tumor lesions, related to poor survival in patients with gastric cancer.

Frontiers in immunology·2025
Same author

Prognostic risk stratification value of MACC1 expression in patients with gastric cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2024
Same author

Pre-operative neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with gastric cancer.

International immunopharmacology·2022
Same author

Editorial: The Biological and Clinical Aspects of HLA-G, Volume II.

Frontiers in immunology·2022
Same journal

The impact of a cancer diagnosis for myeloproliferative neoplasm (MPN) patients.

Expert review of hematology·2026
Same journal

Lessons from warfarin management during the COVID-19 pandemic: from crisis to an opportunity to revolutionize telemedicine for chronic disease care.

Expert review of hematology·2026
Same journal

Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison.

Expert review of hematology·2026
Same journal

Prognostic factors for patients with relapsed or refractory multiple myeloma who are initiating a fourth or later line car T-cell or bispecific antibody therapy: a systematic literature review and meta-analysis.

Expert review of hematology·2026
Same journal

The emerging and evolving role of flow cytometry in myelodysplastic syndrome diagnosis.

Expert review of hematology·2026
Same journal

Anti-CD123 monoclonal antibodies as therapeutic agents for acute myeloid leukemia: a systematic review.

Expert review of hematology·2026
See all related articles

Related Experiment Video

Updated: Jan 1, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.5K

HLA-G expression in hematologic malignancies.

Wei-Hua Yan1

  • 1Medical Research Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical College, Linhai, Zhejiang, People's Republic of China. yanwhcom@yahoo.com

Expert Review of Hematology
|November 19, 2010
PubMed
Summary
This summary is machine-generated.

Human Leukocyte Antigen-G (HLA-G) is an immunomodulatory molecule. This review summarizes HLA-G expression in hematologic malignancies and its link to disease progression, exploring regulatory mechanisms.

More Related Videos

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.7K
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

15.2K

Related Experiment Videos

Last Updated: Jan 1, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.5K
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.7K
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

15.2K

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Human Leukocyte Antigen-G (HLA-G) is a nonclassic MHC class I molecule.
  • HLA-G modulates immune responses by inhibiting immune cells and promoting regulatory cells.
  • Its role in transplantation, autoimmunity, and cancers is widely studied.

Purpose of the Study:

  • To review the expression of HLA-G in hematologic malignancies.
  • To emphasize the clinical relevance of HLA-G expression in disease progression.
  • To highlight potential mechanisms regulating HLA-G expression.

Main Methods:

  • Literature review focusing on studies of HLA-G in hematologic malignancies.
  • Analysis of existing data on HLA-G expression levels and clinical outcomes.
  • Synthesis of information on regulatory pathways of HLA-G.

Main Results:

  • HLA-G expression is observed in various hematologic malignancies, including leukemia and lymphoma.
  • The clinical significance of HLA-G in these diseases is debated but linked to disease progression.
  • Mechanisms controlling HLA-G expression in cancer cells are complex and multifactorial.

Conclusions:

  • HLA-G plays a significant role in the immune microenvironment of hematologic malignancies.
  • Understanding HLA-G's function and regulation may offer therapeutic targets.
  • Further research is needed to clarify the controversial interpretations of HLA-G's clinical significance.